QNRX gets FDA rare pediatric disease designation for QRX003
Quoin Pharmaceuticals said the FDA granted rare pediatric disease designation for QRX003 in peeling skin syndrome.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Quoin Pharmaceuticals said the FDA granted rare pediatric disease designation for QRX003 in peeling skin syndrome.